Učitavanje...

Emerging molecular classification in RCC: implications for drug development

In the past decade, progress has been made in the development of targeted therapies for advanced renal cell carcinoma. However, as multiple therapeutic choices become available for clinicians, we currently lack effective indicators to allow physicians to choose the best treatment option for specific...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hacker, Kathryn E., Rathmell, W. Kimryn
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3392717/
https://ncbi.nlm.nih.gov/pubmed/20645016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-010-0144-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!